Peter Turkstra
The company's website is well-designed and user-friendly. The products are top-notch, and the customer service is excellent. I am really satisfied with my purchase.
Ask AI about Algeta
AI-generated from reviews on this page. Verify anything important with the company directly.
Corey Mills
The company's website is easy to use, and their products are reliable. The customer service team was friendly and resolved my issue promptly.
Tony Froude
I had a great experience with Algeta. Their website is user-friendly and easy to navigate. The products they offer are of high quality and their customer service is excellent. I highly recommend them!
Regina Shepherd
👍 Algeta is an amazing company! Their website is easy to use, and their products are of great quality. The customer service is always prompt and helpful. Highly recommended! 👍
Betsy Larkin-Estes
The company's website is really user-friendly and their products are great. I'm happy with my purchase. 😊
Michael Grier
I'm very satisfied with Algeta. Their website is easy to navigate, and their products are of high quality. The customer service provided quick and efficient assistance.
Sherry Reimer
I had a positive experience with this company. The website is user-friendly, and their products are of good quality. The customer service was friendly and responsive.
Sheila Cochran
Algeta provides exceptional products. The website is intuitive and I had no trouble finding what I needed. Their customer service team was polite and efficient in resolving my queries.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About Algeta
Algeta ASA, an oncology company, focused on developing targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. Its lead product includes radium-223 dichloride, which completed Phase III clinical trial to treat castration-resistant prostate cancer with bone metastases. The company is also developing alpha-emitter thorium-227 that is in the preclinical phase linked to tumor-targeting molecules to form targeted thorium conjugates. It has an agreement with Bayer Pharma AG for the development and commercialization of radium-223 worldwide. The company was formerly known as Anticancer Therapeutic Inventions AS and changed its name to Algeta ASA in 2003. Algeta ASA was founded in 1997 and is headquartered in Oslo, Norway.
- Website
- algeta.com
- post@algeta.com